Treatment and survival of second primary early-stage lung cancer, following treatment of head and neck cancer in the Netherlands
- 1 April 2016
- journal article
- Published by Elsevier in Lung Cancer
- Vol. 94, 54-60
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Results of the Two Incidence Screenings in the National Lung Screening TrialNew England Journal of Medicine, 2013
- Previous Head and Neck Cancers Portend Poor Prognoses in Lung Cancer PatientsThe Annals of Thoracic Surgery, 2011
- Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal CancerJournal of Clinical Oncology, 2011
- Impact of Introducing Stereotactic Lung Radiotherapy for Elderly Patients With Stage I Non–Small-Cell Lung Cancer: A Population-Based Time-Trend AnalysisJournal of Clinical Oncology, 2010
- Variation in treatment and outcome in patients with non-small cell lung cancer by region, hospital type and volume in the NetherlandsEuropean Journal of Surgical Oncology, 2010
- Stage I nonsmall cell lung cancer in patients aged ≥75 yearsCancer, 2009
- Alcohol Consumption and Lung Cancer Risk in the Environment and Genetics in Lung Cancer Etiology (EAGLE) StudyAmerican Journal of Epidemiology, 2009
- Conditional survival in head and neck squamous cell carcinomaCancer, 2007
- The Epidemiology of Second Primary CancersCancer Epidemiology, Biomarkers & Prevention, 2006
- Completeness of Cancer Registration in Limburg, the NetherlandsInternational Journal of Epidemiology, 1993